SE445149B - Latexreagens, som innehaller latexpartiklar sensibiliserade med ett steroid-serumalbuminkonjugat, for immunkemisk bestemning av steroid i mensklig kroppsvetska, samt forfarande for framstellning av reagenset - Google Patents
Latexreagens, som innehaller latexpartiklar sensibiliserade med ett steroid-serumalbuminkonjugat, for immunkemisk bestemning av steroid i mensklig kroppsvetska, samt forfarande for framstellning av reagensetInfo
- Publication number
- SE445149B SE445149B SE7806961A SE7806961A SE445149B SE 445149 B SE445149 B SE 445149B SE 7806961 A SE7806961 A SE 7806961A SE 7806961 A SE7806961 A SE 7806961A SE 445149 B SE445149 B SE 445149B
- Authority
- SE
- Sweden
- Prior art keywords
- steroid
- conjugate
- serum albumin
- latex particles
- latex
- Prior art date
Links
- 239000004816 latex Substances 0.000 title claims description 136
- 150000003431 steroids Chemical class 0.000 title claims description 106
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 49
- 238000000034 method Methods 0.000 title claims description 32
- 108010071390 Serum Albumin Proteins 0.000 title claims description 30
- 102000007562 Serum Albumin Human genes 0.000 title claims description 30
- 238000002360 preparation method Methods 0.000 title claims description 14
- 229920000126 latex Polymers 0.000 claims description 134
- 239000002245 particle Substances 0.000 claims description 101
- 230000004520 agglutination Effects 0.000 claims description 39
- 206010070834 Sensitisation Diseases 0.000 claims description 25
- 230000008313 sensitization Effects 0.000 claims description 25
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 239000002207 metabolite Substances 0.000 claims description 15
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 14
- 102000009027 Albumins Human genes 0.000 claims description 12
- 108010088751 Albumins Proteins 0.000 claims description 12
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- 210000001124 body fluid Anatomy 0.000 claims description 9
- 239000010839 body fluid Substances 0.000 claims description 9
- 239000004793 Polystyrene Substances 0.000 claims description 8
- 229920002223 polystyrene Polymers 0.000 claims description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 7
- 239000000186 progesterone Substances 0.000 claims description 7
- 229960003387 progesterone Drugs 0.000 claims description 7
- 229960000890 hydrocortisone Drugs 0.000 claims description 6
- 239000000262 estrogen Substances 0.000 claims description 5
- 229940011871 estrogen Drugs 0.000 claims description 5
- 230000001235 sensitizing effect Effects 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 3
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 3
- 239000005062 Polybutadiene Substances 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 229920002857 polybutadiene Polymers 0.000 claims description 3
- 229920003048 styrene butadiene rubber Polymers 0.000 claims description 3
- 239000003098 androgen Substances 0.000 claims 4
- 230000000984 immunochemical effect Effects 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 46
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 45
- 230000035945 sensitivity Effects 0.000 description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 239000000725 suspension Substances 0.000 description 39
- 239000007853 buffer solution Substances 0.000 description 38
- 239000000203 mixture Substances 0.000 description 31
- 239000007788 liquid Substances 0.000 description 30
- 239000002244 precipitate Substances 0.000 description 27
- 238000002474 experimental method Methods 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- 239000008367 deionised water Substances 0.000 description 16
- 229910021641 deionized water Inorganic materials 0.000 description 16
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 10
- FQYGGFDZJFIDPU-JRSYHJKYSA-N estriol 16-O-(beta-D-glucuronide) Chemical compound O([C@@H]1C[C@H]2[C@H]3[C@@H](C4=CC=C(O)C=C4CC3)CC[C@@]2([C@H]1O)C)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O FQYGGFDZJFIDPU-JRSYHJKYSA-N 0.000 description 10
- FQYGGFDZJFIDPU-UHFFFAOYSA-N estriol 16alpha-beta-D-glucuronide Natural products OC1C2(C)CCC(C3=CC=C(O)C=C3CC3)C3C2CC1OC1OC(C(O)=O)C(O)C(O)C1O FQYGGFDZJFIDPU-UHFFFAOYSA-N 0.000 description 10
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 9
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 9
- 229960002847 prasterone Drugs 0.000 description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 8
- 229960002319 barbital Drugs 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 6
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 6
- 230000001900 immune effect Effects 0.000 description 6
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- PLOJJUOTOYNIGL-GFCCVEGCSA-N (2r)-6-amino-2-nitro-2-(n-nitroanilino)hexanoic acid Chemical compound NCCCC[C@@]([N+]([O-])=O)(C(O)=O)N([N+]([O-])=O)C1=CC=CC=C1 PLOJJUOTOYNIGL-GFCCVEGCSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- 239000003270 steroid hormone Substances 0.000 description 3
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- LRCVOOBIVXNBIT-NQUDVWKHSA-N bis[2-[(8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] butanedioate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]([C@@H](O)C[C@]23C)[C@@H]1[C@@H]3CC[C@]2(O)C(=O)COC(=O)CCC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@H](CCC=3[C@@]4(CCC(=O)C=3)C)[C@@H]4[C@@H](O)C[C@@]21C LRCVOOBIVXNBIT-NQUDVWKHSA-N 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 2
- 229960001348 estriol Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229930182480 glucuronide Natural products 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- -1 steroid glucuronide Chemical class 0.000 description 2
- NQRKYASMKDDGHT-UHFFFAOYSA-N (aminooxy)acetic acid Chemical compound NOCC(O)=O NQRKYASMKDDGHT-UHFFFAOYSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 1
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- HHZQLQREDATOBM-CODXZCKSSA-M Hydrocortisone Sodium Succinate Chemical compound [Na+].O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COC(=O)CCC([O-])=O)[C@@H]4[C@@H]3CCC2=C1 HHZQLQREDATOBM-CODXZCKSSA-M 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000000431 corpus luteum hormone Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N hydroxylamine hydrochloride Substances Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- 229960002899 hydroxyprogesterone Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229950009829 prasterone sulfate Drugs 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000005845 steroid sulfates Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NIKZPECGCSUSBV-HMAFJQTKSA-N testosterone 17-glucosiduronic acid Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(CCC(=O)C=C4CC3)C)CC[C@@]21C)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O NIKZPECGCSUSBV-HMAFJQTKSA-N 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52072775A JPS5819222B2 (ja) | 1977-06-21 | 1977-06-21 | ステロイド−血清アルブミン複合体感作ラテックス粒子の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7806961L SE7806961L (sv) | 1978-12-22 |
| SE445149B true SE445149B (sv) | 1986-06-02 |
Family
ID=13499080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7806961A SE445149B (sv) | 1977-06-21 | 1978-06-16 | Latexreagens, som innehaller latexpartiklar sensibiliserade med ett steroid-serumalbuminkonjugat, for immunkemisk bestemning av steroid i mensklig kroppsvetska, samt forfarande for framstellning av reagenset |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4226847A (xx) |
| JP (1) | JPS5819222B2 (xx) |
| AU (1) | AU522306B2 (xx) |
| CA (1) | CA1107196A (xx) |
| DE (1) | DE2827250C2 (xx) |
| DK (1) | DK151400C (xx) |
| FR (1) | FR2395507A1 (xx) |
| GB (1) | GB2001992B (xx) |
| NL (1) | NL7806681A (xx) |
| SE (1) | SE445149B (xx) |
| SU (1) | SU1213975A3 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4331657A (en) * | 1980-02-06 | 1982-05-25 | Commonwealth Scientific And Industrial Research Organization | Fecundity of domestic livestock |
| NZ196126A (en) * | 1980-02-07 | 1985-05-31 | Commw Scient Ind Res Org | Increasing ovulation rate in female cattle |
| US4340564A (en) * | 1980-07-21 | 1982-07-20 | Daryl Laboratories, Inc. | Immunoadsorptive surface coating for solid-phase immunosubstrate and solid-phase immunosubstrate |
| JPS589068A (ja) * | 1981-07-10 | 1983-01-19 | Eiken Kagaku Kk | エストリオ−ル−１６α−グルクロニドの免疫化学的測定法 |
| US4792527A (en) * | 1981-07-17 | 1988-12-20 | Toray Industries, Inc. | Method of assaying biologically active substances and labelling agents therefor |
| US4738932A (en) * | 1985-12-03 | 1988-04-19 | Advanced Polymer Systems, Inc. | Reaginic test for syphilis |
| ES2028124T3 (es) * | 1987-04-22 | 1992-07-01 | Schiapparelli Biosystems, Inc. | Metodo para la determinacion de albumina en fluidos biologicos. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL125235C (xx) * | 1965-04-15 | |||
| JPS5226644B2 (xx) * | 1972-05-30 | 1977-07-15 | ||
| JPS5513306B2 (xx) * | 1973-11-29 | 1980-04-08 | ||
| JPS5434818B2 (xx) * | 1974-03-14 | 1979-10-29 | ||
| BE821053A (fr) * | 1974-08-01 | 1975-04-14 | Produit pour diagnostic par determination immunochimique | |
| JPS51112513A (en) * | 1975-03-25 | 1976-10-05 | Asahi Chem Ind Co Ltd | A method for determination of dha.sulfate |
-
1977
- 1977-06-21 JP JP52072775A patent/JPS5819222B2/ja not_active Expired
-
1978
- 1978-06-08 AU AU36945/78A patent/AU522306B2/en not_active Expired
- 1978-06-12 CA CA305,252A patent/CA1107196A/en not_active Expired
- 1978-06-16 SE SE7806961A patent/SE445149B/sv not_active IP Right Cessation
- 1978-06-20 DK DK277178A patent/DK151400C/da not_active IP Right Cessation
- 1978-06-20 GB GB7827369A patent/GB2001992B/en not_active Expired
- 1978-06-20 US US05/917,254 patent/US4226847A/en not_active Expired - Lifetime
- 1978-06-21 NL NL7806681A patent/NL7806681A/xx not_active Application Discontinuation
- 1978-06-21 FR FR7818613A patent/FR2395507A1/fr active Granted
- 1978-06-21 SU SU782629447A patent/SU1213975A3/ru active
- 1978-06-21 DE DE2827250A patent/DE2827250C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU3694578A (en) | 1979-12-13 |
| US4226847A (en) | 1980-10-07 |
| DK151400C (da) | 1988-05-16 |
| SU1213975A3 (ru) | 1986-02-23 |
| DE2827250A1 (de) | 1979-01-04 |
| FR2395507B1 (xx) | 1984-10-26 |
| DE2827250C2 (de) | 1986-03-06 |
| GB2001992A (en) | 1979-02-14 |
| NL7806681A (nl) | 1978-12-27 |
| AU522306B2 (en) | 1982-05-27 |
| DK151400B (da) | 1987-11-30 |
| JPS5819222B2 (ja) | 1983-04-16 |
| SE7806961L (sv) | 1978-12-22 |
| GB2001992B (en) | 1982-03-24 |
| FR2395507A1 (fr) | 1979-01-19 |
| JPS548715A (en) | 1979-01-23 |
| DK277178A (da) | 1978-12-22 |
| CA1107196A (en) | 1981-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4308026A (en) | Agglutination inhibition immunoassay for hapten using two differently sensitized particles | |
| CA2365565C (en) | Detection methods | |
| US7488608B2 (en) | Reduction of non-specific binding in assays | |
| EP0177531B1 (en) | Antibodies, manufacture and use | |
| EP0668504A1 (en) | Quaternary ammonium immunogenic conjugates and immunoassay reagent | |
| JP5735615B2 (ja) | 免疫学的測定における感度増強方法及びそのための試薬 | |
| DE69321657T2 (de) | Zweistufenverfahren zur Antikörperbeschichtung von Festphasen | |
| DE69620876T2 (de) | Bestimmung von steroiden durch kompetitiven immunoassay | |
| JPWO2019098314A1 (ja) | シクロデキストリンに包接されたステロイドの脱包接に用いるための処理液 | |
| JP5055289B2 (ja) | アッセイにおける非特異的結合の低減 | |
| SE445149B (sv) | Latexreagens, som innehaller latexpartiklar sensibiliserade med ett steroid-serumalbuminkonjugat, for immunkemisk bestemning av steroid i mensklig kroppsvetska, samt forfarande for framstellning av reagenset | |
| DE69524842T2 (de) | Verfahren zur Kupplung eines Antikörpers an einen Latexpartikel und dessen Verwendung in einem Immunoassay | |
| Bodmer et al. | Antigen-versus antibody-immobilized ELISA procedures based on a biotinyl-estradiol conjugate | |
| CA1223812A (en) | Immunoassay | |
| CA2093494A1 (en) | Method for the elimination of non-specific reactions in immuno-assays | |
| EP1064552B1 (en) | Immunoassays using casein coating of particles | |
| EP2742352B1 (en) | Detection of sex steroids | |
| EP1597579A2 (en) | Generic method for latex agglutination assays | |
| JPS60249058A (ja) | Ａｔｌウイルス抗体の測定方法および試薬 | |
| CN118393132A (zh) | 一种单表位抗原标记方法、抗原标记物、试剂盒及应用 | |
| JPH11248703A (ja) | 遊離ハプテンの免疫学的測定法 | |
| JP2000329768A (ja) | 免疫測定試薬及び免疫測定試薬の製造方法 | |
| JPH11194127A (ja) | ハプテン抗原結合固相及びそれを用いた免疫測定方法 | |
| WO1993020448A1 (en) | Non-instrumented enzyme immunoassay: general method utilizing kinetic binding effects | |
| JPS61132867A (ja) | エストリオ−ル３−サルフエ−トのイムノアツセイ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7806961-4 Effective date: 19940110 Format of ref document f/p: F |